Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability
{{output}}
Understanding the mechanisms governing metabolic reprogramming that underlie potential vulnerabilities in cancer cells is key to developing novel therapeutic strategies. The catalytic enzyme UDP-glucose pyrophosphorylase 2 (UGP2) drives the production of UDP-g... ...
